2024-11-12 23:07:47 ET
Voyager Therapeutics, Inc. (VYGR)
Q3 2024 Results Earnings Conference Call
November 12, 2024, 04:30 PM ET
Company Participants
Trista Morrison - Chief Corporate Affairs Officer and Chief of Staff to the CEO
Alfred Sandrock - President and Chief Executive Officer
Toby Ferguson - Chief Medical Officer
Todd Carter - Chief Scientific Officer
Nathan Jorgensen - Chief Financial Officer
Conference Call Participants
Phil Nadeau - TD Cowen
Jack Allen - Robert W. Baird
Joon Lee - Truist Securities
Jay Olson - Oppenheimer & Co.
Lili Nsongo - Leerink Partners
Patrick Trucchio - HC Wainwright
Presentation
Operator
Good afternoon, and welcome to the Voyager Therapeutics Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call. Please note that today's call is being recorded. A replay of today's call will be available on the Investors section of the company website approximately two hours after completion of this call.
I would now like to turn the call over to Trista Morrison, Chief Corporate Affairs Officer at Voyager.
Trista Morrison
Thank you. And good afternoon. We issued our third quarter 2024 financial results press release this afternoon. The press release and 10-Q are available on our website.
Joining me on today's call are Dr. Al Sandrock, our Chief Executive Officer; Dr. Toby Ferguson, our Chief Medical Officer; and Dr. Todd Carter, our Chief Scientific Officer. We will also be joined for the Q&A portion of the call by Dr. Nathan Jorgensen, our Chief Financial Officer....
Read the full article on Seeking Alpha
For further details see:
Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript
